Levosulpiride‐induced movement disorders
Identifieur interne : 002232 ( Main/Exploration ); précédent : 002231; suivant : 002233Levosulpiride‐induced movement disorders
Auteurs : Hae-Won Shin [Corée du Sud] ; Mi J. Kim [Corée du Sud] ; Jong S. Kim [Corée du Sud] ; Myoung C. Lee [Corée du Sud] ; Sun J. Chung [Corée du Sud]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-11-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antipsychotic Agents (adverse effects), Brain (pathology), Dyskinesia, Female, Humans, Levosulpiride, Magnetic Resonance Imaging (methods), Male, Middle Aged, Movement Disorders (classification), Movement Disorders (diagnosis), Movement Disorders (etiology), Nervous system diseases, Parkinson Disease (etiology), Parkinsonism, Retrospective Studies, Substance abuse, Sulpiride (adverse effects), Sulpiride (analogs & derivatives), Tremor, Tremor (chemically induced), drug‐induced movement disorders, dyskinesia, levosulpiride, tremor.
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Sulpiride.
- chemical , analogs & derivatives : Sulpiride.
- chemically induced : Tremor.
- classification : Movement Disorders.
- diagnosis : Movement Disorders.
- etiology : Movement Disorders, Parkinson Disease.
- methods : Magnetic Resonance Imaging.
- pathology : Brain.
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies.
Abstract
Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis. However, little is known about levosulpiride‐induced movement disorders (LIM). The aim of this study was to investigate the clinical characteristics of patients with LIM. Among 132 consecutive patients who were diagnosed with drug‐induced movement disorders between January 2002 and March 2008, 91 patients with LIM were identified and their medical records reviewed. Seventy‐eight (85.7%) patients were aged more than 60 years. The most common LIM was parkinsonism (LIP) (n = 85, 93.4%), followed by tardive dyskinesia (n = 9, 9.9%) and isolated tremor (n = 3, 3.3%). Twenty‐one (24.7%) of the 85 patients with LIP were rated as Hoehn and Yahr stage III–V. The oro‐lingual area was the only body part that was involved by tardive dyskinesia. LIM persisted after withdrawal of levosulpiride in 48.1% of patients with LIP, 66.7% with dyskinesia, and none with isolated tremor. None of clinical and MRI features predicted the reversibility of LIP. Levosulpiride frequently causes drug‐induced movement disorders, presenting mainly with LIP followed by lower face dyskinesia. The symptoms are often severe, and irreversible even after the withdrawal of levosulpiride. Physicians should be cautious in using levosulpiride, especially in elderly patients. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22805
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C86
- to stream Istex, to step Curation: 001C86
- to stream Istex, to step Checkpoint: 000E34
- to stream PubMed, to step Corpus: 001B44
- to stream PubMed, to step Curation: 001B44
- to stream PubMed, to step Checkpoint: 001D39
- to stream Ncbi, to step Merge: 002836
- to stream Ncbi, to step Curation: 002836
- to stream Ncbi, to step Checkpoint: 002836
- to stream Main, to step Merge: 002A93
- to stream PascalFrancis, to step Corpus: 000C95
- to stream PascalFrancis, to step Curation: 002024
- to stream PascalFrancis, to step Checkpoint: 000E22
- to stream Main, to step Merge: 002F19
- to stream Main, to step Curation: 002232
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levosulpiride‐induced movement disorders</title><author><name sortKey="Shin, Hae On" sort="Shin, Hae On" uniqKey="Shin H" first="Hae-Won" last="Shin">Hae-Won Shin</name></author><author><name sortKey="Kim, Mi J" sort="Kim, Mi J" uniqKey="Kim M" first="Mi J." last="Kim">Mi J. Kim</name></author><author><name sortKey="Kim, Jong S" sort="Kim, Jong S" uniqKey="Kim J" first="Jong S." last="Kim">Jong S. Kim</name></author><author><name sortKey="Lee, Myoung C" sort="Lee, Myoung C" uniqKey="Lee M" first="Myoung C." last="Lee">Myoung C. Lee</name></author><author><name sortKey="Chung, Sun J" sort="Chung, Sun J" uniqKey="Chung S" first="Sun J." last="Chung">Sun J. Chung</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0E863B81DEB3FE5A3F083702B586A9FCC29E9D9C</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22805</idno><idno type="url">https://api.istex.fr/document/0E863B81DEB3FE5A3F083702B586A9FCC29E9D9C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001C86</idno><idno type="wicri:Area/Istex/Curation">001C86</idno><idno type="wicri:Area/Istex/Checkpoint">000E34</idno><idno type="wicri:doubleKey">0885-3185:2009:Shin H:levosulpiride:induced:movement</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19795476</idno><idno type="wicri:Area/PubMed/Corpus">001B44</idno><idno type="wicri:Area/PubMed/Curation">001B44</idno><idno type="wicri:Area/PubMed/Checkpoint">001D39</idno><idno type="wicri:Area/Ncbi/Merge">002836</idno><idno type="wicri:Area/Ncbi/Curation">002836</idno><idno type="wicri:Area/Ncbi/Checkpoint">002836</idno><idno type="wicri:Area/Main/Merge">002A93</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:10-0036284</idno><idno type="wicri:Area/PascalFrancis/Corpus">000C95</idno><idno type="wicri:Area/PascalFrancis/Curation">002024</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000E22</idno><idno type="wicri:doubleKey">0885-3185:2009:Shin H:levosulpiride:induced:movement</idno><idno type="wicri:Area/Main/Merge">002F19</idno><idno type="wicri:Area/Main/Curation">002232</idno><idno type="wicri:Area/Main/Exploration">002232</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levosulpiride‐induced movement disorders</title><author><name sortKey="Shin, Hae On" sort="Shin, Hae On" uniqKey="Shin H" first="Hae-Won" last="Shin">Hae-Won Shin</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Parkinson/Alzheimer Center, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Mi J" sort="Kim, Mi J" uniqKey="Kim M" first="Mi J." last="Kim">Mi J. Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Parkinson/Alzheimer Center, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Jong S" sort="Kim, Jong S" uniqKey="Kim J" first="Jong S." last="Kim">Jong S. Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Parkinson/Alzheimer Center, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Lee, Myoung C" sort="Lee, Myoung C" uniqKey="Lee M" first="Myoung C." last="Lee">Myoung C. Lee</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Parkinson/Alzheimer Center, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Chung, Sun J" sort="Chung, Sun J" uniqKey="Chung S" first="Sun J." last="Chung">Sun J. Chung</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Parkinson/Alzheimer Center, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-11-15">2009-11-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">15</biblScope><biblScope unit="page" from="2249">2249</biblScope><biblScope unit="page" to="2253">2253</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">0E863B81DEB3FE5A3F083702B586A9FCC29E9D9C</idno><idno type="DOI">10.1002/mds.22805</idno><idno type="ArticleID">MDS22805</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antipsychotic Agents (adverse effects)</term><term>Brain (pathology)</term><term>Dyskinesia</term><term>Female</term><term>Humans</term><term>Levosulpiride</term><term>Magnetic Resonance Imaging (methods)</term><term>Male</term><term>Middle Aged</term><term>Movement Disorders (classification)</term><term>Movement Disorders (diagnosis)</term><term>Movement Disorders (etiology)</term><term>Nervous system diseases</term><term>Parkinson Disease (etiology)</term><term>Parkinsonism</term><term>Retrospective Studies</term><term>Substance abuse</term><term>Sulpiride (adverse effects)</term><term>Sulpiride (analogs & derivatives)</term><term>Tremor</term><term>Tremor (chemically induced)</term><term>drug‐induced movement disorders</term><term>dyskinesia</term><term>levosulpiride</term><term>tremor</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term><term>Sulpiride</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Sulpiride</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Movement Disorders</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Abus de substance</term><term>Dyskinésie</term><term>Lévosulpiride</term><term>Parkinsonisme</term><term>Pathologie du système nerveux</term><term>Tremblement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis. However, little is known about levosulpiride‐induced movement disorders (LIM). The aim of this study was to investigate the clinical characteristics of patients with LIM. Among 132 consecutive patients who were diagnosed with drug‐induced movement disorders between January 2002 and March 2008, 91 patients with LIM were identified and their medical records reviewed. Seventy‐eight (85.7%) patients were aged more than 60 years. The most common LIM was parkinsonism (LIP) (n = 85, 93.4%), followed by tardive dyskinesia (n = 9, 9.9%) and isolated tremor (n = 3, 3.3%). Twenty‐one (24.7%) of the 85 patients with LIP were rated as Hoehn and Yahr stage III–V. The oro‐lingual area was the only body part that was involved by tardive dyskinesia. LIM persisted after withdrawal of levosulpiride in 48.1% of patients with LIP, 66.7% with dyskinesia, and none with isolated tremor. None of clinical and MRI features predicted the reversibility of LIP. Levosulpiride frequently causes drug‐induced movement disorders, presenting mainly with LIP followed by lower face dyskinesia. The symptoms are often severe, and irreversible even after the withdrawal of levosulpiride. Physicians should be cautious in using levosulpiride, especially in elderly patients. © 2009 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Corée du Sud</li></country><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><noRegion><name sortKey="Shin, Hae On" sort="Shin, Hae On" uniqKey="Shin H" first="Hae-Won" last="Shin">Hae-Won Shin</name></noRegion><name sortKey="Chung, Sun J" sort="Chung, Sun J" uniqKey="Chung S" first="Sun J." last="Chung">Sun J. Chung</name><name sortKey="Kim, Jong S" sort="Kim, Jong S" uniqKey="Kim J" first="Jong S." last="Kim">Jong S. Kim</name><name sortKey="Kim, Mi J" sort="Kim, Mi J" uniqKey="Kim M" first="Mi J." last="Kim">Mi J. Kim</name><name sortKey="Lee, Myoung C" sort="Lee, Myoung C" uniqKey="Lee M" first="Myoung C." last="Lee">Myoung C. Lee</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002232 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002232 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0E863B81DEB3FE5A3F083702B586A9FCC29E9D9C
|texte= Levosulpiride‐induced movement disorders
}}
| This area was generated with Dilib version V0.6.23. |  |